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Background: Behavioral effects of stimulant drugs are influenced by non-pharmacological factors, including
genetic variability and age. We examined acute and sensitized locomotor effects of methylphenidate in adolescent
and early adult male Sprague Dawley (SD), spontaneously hypertensive (SHR) and Wistar Kyoto (WKY) rats using a
drug regimen that differentiates clearly between initial and enduring differences in drug responsiveness. We probed
for strain and age differences in the sensitizing effects of methylphenidate using a cocaine challenge.
Methylphenidate was administered to the rats in a non-home environment.
Findings: Strain differences in sensitivity to single methylphenidate injections depend on age and change with
continuing drug pretreatment. While SHR rats are more sensitive to methylphenidate relative to WKY regardless of
age and pretreatment day, SHR rats become more sensitive to methylphenidate than SD rats towards the end of
pretreatment during early adulthood. SD rats exhibit greater sensitivity to methylphenidate relative to the WKY
group during adolescence, an effect that dissipates with continued drug pretreatment during adulthood.
Remarkably, only SHR rats, regardless of age, exhibit methylphenidate-induced cross-sensitization to the behavioral
effects of cocaine.
Conclusions: Our findings suggest that SHR rats are more vulnerable than other strains to methylphenidate-induced
cross-sensitization to cocaine, at least when methylphenidate is administered in a non-home environment. Given that
SHR rats are typically used to model features of attention deficit hyperactivity disorder, these findings may have
important implications for the treatment of this disorder with methylphenidate.
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Acute and chronic locomotor and neurochemical effects
of stimulant drugs are determined not only by the
pharmacological properties of the drug itself, but also
by a multitude of non-pharmacological factors, such as
genetic variability and age [1-8]. Recently, Dafny and
colleagues reported strain differences in sensitization
to the locomotor activating effects of methylphenidate
between Sprague Dawley (SD), spontaneously hypertensive
(SHR) and Wistar Kyoto (WKY) rats, the extent of which
was shown to depend on age [9-11], reviewed in [12].* Correspondence: a.arvanitogiannis@concordia.ca
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distribution, and reproduction in any mediumBecause SHR rats are typically used to model features of
attention deficit hyperactivity disorder (ADHD), such find-
ings are particularly salient and warrant further exploration.
In the aforementioned studies by Dafny and colleagues
[9-11], rats were pretreated with methylphenidate in
their home cages and, following a short withdrawal period
(2 days), were tested for sensitization with a methylphen-
idate challenge. Here we examined strain and age differ-
ences in the acute and cross-sensitizing behavioral effects
of methylphenidate by pretreating rats with the drug in an
environment other than home, as administering the drug
to rats in the environment in which they live is known to
attenuate the locomotor activating effects of stimulant
drugs [13]. We also used a drug treatment regimen
that differentiates clearly between initial and long-lastingBioMed Central Ltd. This is an open access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Diagrammatic illustration of experimental procedures conducted in adolescent and early adult Spontaneously Hypertensive,
Sprague Dawley, and Wistar Kyoto rats. MPH: methylphenidate.
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effects are often detected soon after drug exposure, their
magnitude increases over time [14-16], indicating that
neuroadaptations underlying sensitization continue to
develop long after the end of repeated drug pretreatment.
Sensitization effects observed at early withdrawal times are
likely to rely on transient changes in receptor function
[17-19], whereas enduring sensitization requires long-
lasting, perhaps permanent, neuroadaptations [19,20].
Moreover, to assess the generalizability of methylphenidate-
induced sensitization to illicit drugs, we probed strain and
age differences in the enduring sensitizing effects of methyl-
phenidate using a cocaine, rather than a methylphenidate
challenge. This study was approved by the Concordia
University Animal Research Ethics Committee.
Figure 1 illustrates the design of the experiment. Briefly,
adolescent and early adult male SD (adolescent: 100-120 g;
early adult: 220-270 g), SHR (adolescent: 110-140 g; early
adult: 160-180 g), and WKY (adolescent: 70-110 g; early
adult: 170-190 g) rats (Charles River, St Constant, Quebec)
were housed in pairs in a room with a 12-hr light-12-hr
dark cycle (n = 6 for all groups unless stated otherwise).
Rats arrived to the animal colony at five (adolescent) and
eight (early adult) weeks of age and were given a few days
to acclimate before commencement of drug pretreatment.
Locomotor activity was assessed in testing chambers
(40.2 × 20.2 × 30.5 cm) with transparent Plexiglas fronts,
stainless steel grid floors, and wooden side walls, backs,Figure 2 Behavioral responses to the first injection of methylphenida
Sprague Dawley, and Wistar Kyoto rats. * p < .05, significantly different
different from Spontaneously Hypertensive rat. **** p < .0001, significantly
pretreated with methylphendiate, n = 5. All other groups, n = 6. SHR: Spon
MPH: methylphenidate.and ceilings. A single count of locomotor activity was de-
fined as a consecutive interruption of two photocells that
were located along the longitudinal axis of each chamber,
4.8 cm above the floor. The first part of the experiment
(pretreatment) lasted ten consecutive days, wherein we
transported animals to the testing chambers and adminis-
tered injections of saline (1 ml/kg i.p.) or methylphenidate
(2.5 mg/kg i.p.; methylphenidate hydrochloride, Medisca,
QC, Canada). This dose was selected because it was pre-
viously shown to be the lowest dose to elicit behavioral
activation in the three rat strains used in the present
study [11]. Locomotor activity was recorded for 30 min
and the animals were then returned to their home cage.
The second part of the experiment (test) took place ten
days following the last pretreatment injection. During
this test, we gave all animals a challenge injection of cocaine
(5 mg/kg i.p., cocaine hydrochloride, Medisca). This low
dose was chosen so as to elicit locomotion during the
test, rather than stereotypy [21]. Locomotor activity was
recorded for 1 hr. Two- and three-way ANOVAs were
used as required to analyze behavioral effects. Significant
main effects and interactions were followed by Tukey
post-hoc tests.
As shown in Figure 2, the first injection of methylphenidate
administered to adolescent SD, SHR and WKY rats induced
an increase in locomotor activity (Two-way ANOVA
(strain × drug treatment); significant main effect of drug
treatment: F(1, 30) = 29.93, p < .0001). However, WKY rats,te in adolescent and early adult Spontaneously Hypertensive,
from Spontaneously Hypertensive rat. *** p < .001, significantly
different from methylphenidate-treated animals. Adult SHR group
taneously Hypertensive rat; SD: Sprague Dawley; WKY: Wistar Kyoto;
Figure 3 Behavioral responses to injections of methylphenidate or
saline in adolescent and early adult Spontaneously Hypertensive,
Sprague Dawley, and Wistar Kyoto rats across the 10 pretreatment
days. Filled symbols represent methylphenidate-treated animals. Open
symbols represent saline-treated animals. Circles, squares and
triangles represent Spontaneously Hypertensive, Sprague Dawley,
and Wistar Kyoto rats, respectively. Adult SHR group pretreated
with methylphendiate, n = 5. All other groups, n = 6. Please see text for
statistical results. SHR: Spontaneously Hypertensive rat; SD: Sprague
Dawley; WKY: Wistar Kyoto; MPH: methylphenidate; Sal: saline.
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less locomotor activity than SHR rats (significant main
effect of strain: F(2, 30) = 4.12, p = .02; significant difference
between WKY and SHR rats, p < .05). An acute injection
of methylphenidate also increased locomotor activity
within early adult rats, however, the WKY group exhibited
lower methylphenidate-induced locomotor activity in
comparison to the SHR group (Two-way ANOVA
(strain × drug treatment); significant main effect of drug
treatment: F(1, 29) = 71.32, p < .0001; significant strain ×
drug treatment interaction: F(2, 29) = 4.45, p = .02; signifi-
cant difference between methylphenidate treated SHR and
methylphenidate treated WKY, p < .001). These results are
in stark contrast to the findings of Dafny and colleagues
[9-11], showing that SHR rats respond less to acute
methylphenidate in comparison to SD and WKY groups.
This key difference between our findings likely reflects the
influence of environmental context in the modulation of
the locomotor-activating effects of stimulant drugs [13]
and suggests that SHR rats may be more sensitive than
other strains to the attenuating effects of the home envir-
onment on stimulant-induced locomotor activity. Of note,
the baseline hyperactivity typically associated with SHR
rats was observed only in comparison to WKY rats, and
only within the adolescent group.
Across multiple pretreatment days (Figure 3), locomotor
activity remained elevated in response to methylphenidate
administration as compared to saline in both adolescent
and early adult SHR, WKY, and SD rats (adolescent group;
Three-way ANOVA (strain × drug pretreatment × day):
significant main effect of drug pretreatment: F(1, 30) =
84.44, p < .0001; early adult group; Three-way ANOVA
(strain × drug pretreatment × day): significant main effect
of drug pretreatment: F(1, 29) = 116.68, p < .0001). Within
the adolescent group, the magnitude of locomotor activity
elicited by methylphenidate was greater in SHR and SD rats
compared to WKY rats (significant drug treatment × strain
interaction: F(2, 30) = 4.49, p = .02; significant differences
between SHR and SD rats with WKY rats, p < .01). Within
the early adult group, however, the picture is more complex
because strain differences in methylphenidate-induced
locomotor activity differ as a function of pretreatment day
(significant drug pretreatment × strain × day interaction:
F(18, 29) = 4.57, p < .0001. Specifically, while it is clear
that SHR and SD groups exhibit similar drug-induced
locomotor activity on the first five pretreatment days,
the SHR group (n = 5) shows a dramatically greater re-
sponse to methylphenidate on the remaining days than
the SD group (p < .01). In comparison to WKY rats, the
SHR group shows significantly greater activity across all pre-
treatment days, excepting day 5 (day 1, p < .05; days 2 – 4,
p < .01; days 6 – 9, p < .01; day 10, p < .05). SD rats exhibit
similar levels of methylphenidate-induced locomotor
activity to WKY rats except for pretreatment days 4and 5, wherein SD rats exhibit greater behavioral effects
than WKY rats (p < .05). Thus, these findings reveal that
the strain differences in sensitivity to methylphenidate
change with continuing drug pretreatment. While SHR
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to WKY regardless of age and daily drug exposure, SHR
rats become more sensitive to methylphenidate than SD
rats towards the end of pretreatment during early adult-
hood. In a similar way, SD rats exhibit greater sensitivity
to methylphenidate relative to the WKY group during
adolescence, an effect that dissipates with continued
drug pretreatment during early adulthood.
Results of the sensitization test are shown in Figure 4.
Sensitization is defined as a greater response to the drug
challenge injection in drug- versus saline-pretreated ani-
mals within each strain. It is remarkable that, at both ages,
only SHR rats exhibit methylphenidate-induced cross-
sensitization to the behavioral effects of cocaine (adolescent
group: Two-way ANOVA (drug pretreatment × time):
significant drug × time interaction, F(3, 30) = 9.1, p < .0001;
significant differences at 15 min, p < .0001; early adultFigure 4 Behavioral responses to a challenge injection of cocaine in S
rats pretreated with methylphenidate or saline during adolescence o
methylphenidate-induced behavioral cross-sensitization to cocaine. Adult S
n = 6. Please see text for statistical results. SHR: Spontaneously Hypertensiv
Sal: saline.group: Two-way ANOVA (drug pretreatment × time):
significant drug × time interaction, F(3, 29) = 18.1, p < .0001;
significant differences at 15 - 30 min, p < .0001 and at
45 min, p < .05). It should be noted that pretreatment with
methylphenidate may have altered the baseline locomotor
activity of SHR rats, and thus the augmented locomotor
response may be a composite of sensitized baseline loco-
motor activity and sensitized cocaine-induced locomotion.
The absence of sensitization in SD and WKYgroups is un-
likely to be due to increased stereotypy because of the low
cocaine dose used to probe for sensitization [21].
These results are not in accord with the conclusion
reached by Dafny and colleagues that “the SHR group
is the least susceptible to development of behavioral
sensitization” [10]. Rather, our results suggest that SHR rats
are more vulnerable than other strains to methylphenidate-
induced cross-sensitization to the locomotor-activatingpontaneously Hypertensive, Sprague Dawley, and Wistar Kyoto
r early adulthood. Only Spontaneously Hypertensive rats exhibit
HR group pretreated with methylphendiate, n = 5. All other groups,
e rat; SD: Sprague Dawley; WKY: Wistar Kyoto; MPH: methylphenidate;
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tered in an environment other than home. While the
present results are limited to cross-sensitization of the
locomotor-activating effects of methylphenidate and
cocaine, our findings suggest that individuals with ADHD
that are treated with methylphenidate may have greater
vulnerability to abuse illicit drugs than normal individuals,
a possibility that has recently been supported [22], but
see [23-25].
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